Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 182

    1.

    The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.

    Rubio-Guerra AF, Arceo-Navarro A, Vargas-Ayala G, Rodriguez-Lopez L, Lozano-Nuevo JJ, Gomez-Harper CT.

    Diabetes Care. 2004 Jul;27(7):1688-91.PMID: 15220247 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.

    Rubio-Guerra AF, Vargas-Robles H, Vargas-Ayala G, Rodriguez-Lopez L, Escalante-Acosta BA.

    Clin Exp Hypertens. 2008 Oct;30(7):682-8.PMID: 18855271 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.

    Hemmelder MH, de Zeeuw D, de Jong PE.

    Nephrol Dial Transplant. 1999 Jan;14(1):98-104.PMID: 10052485 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

    Ruilope LM, Usan L, Segura J, Bakris GL.

    J Hypertens. 2004 Jan;22(1):217-22.PMID: 15106814 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.

    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.

    Am J Nephrol. 2000 Sep-Oct;20(5):373-9.PMID: 11092994 [PubMed - indexed for MEDLINE]Related articles

    6.

    Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial.

    PROCOPA Study Group.

    J Hypertens. 2002 Apr;20(4):729-37.PMID: 11910310 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

    Bakris GL, Weir MR, DeQuattro V, McMahon FG.

    Kidney Int. 1998 Oct;54(4):1283-9.PMID: 9767545 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.

    Toto RD, Tian M, Fakouhi K, Champion A, Bacher P.

    J Clin Hypertens (Greenwich). 2008 Oct;10(10):761-9.PMID: 19090877 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.

    García de Vinuesa S, Luño J, Gómez-Campderá F, Ridao N, Sánchez M, Dall'Anese C, Valderrábano F.

    Nephrol Dial Transplant. 2001;16 Suppl 1:78-81.PMID: 11369828 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.

    Muijsers RB, Curran MP, Perry CM.

    Drugs. 2002;62(17):2539-67. Review.PMID: 12421112 [PubMed - indexed for MEDLINE]Related articles

    11.

    A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

    Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators.

    JAMA. 2003 Dec 3;290(21):2805-16.PMID: 14657064 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.

    Otero ML, Claros NM; Study Investigators Group.

    Clin Ther. 2005 Feb;27(2):166-73.PMID: 15811479 [PubMed - indexed for MEDLINE]Related articles

    13.

    Verapamil versus amlodipine in proteinuric non-diabetic nephropathies treated with trandolapril (VVANNTT study): design of a prospective randomized multicenter trial.

    Boero R, Rollino C, Massara C, Vagelli G, Gonella M, Berto IM, Bajardi P, Perosa P, Malcangi U, Giorgi MP, Ghezzi PM, Borzumati M, Baroni AM, Cogno C, Triolo G, Angelini D, Antonelli A, Quarello F.

    J Nephrol. 2001 Jan-Feb;14(1):15-8.PMID: 11281338 [PubMed - indexed for MEDLINE]Related articles

    14.

    Preventing microalbuminuria in type 2 diabetes.

    Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G; Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators.

    N Engl J Med. 2004 Nov 4;351(19):1941-51. Epub 2004 Oct 31.PMID: 15516697 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril.

    New JP, Bilous RW, Walker M.

    Diabet Med. 2000 Feb;17(2):134-40.PMID: 10746484 [PubMed - indexed for MEDLINE]Related articles

    16.

    Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.

    Holzgreve H, Nakov R, Beck K, Janka HU.

    Am J Hypertens. 2003 May;16(5 Pt 1):381-6.PMID: 12745200 [PubMed - indexed for MEDLINE]Related articles

    17.

    The fixed combination of verapamil SR/trandolapril.

    Widimský J.

    Expert Opin Pharmacother. 2000 Mar;1(3):515-35. Review.PMID: 11249535 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination.

    Oren S, Viskoper JR, Zilles P.

    Int J Cardiol. 1996 Jul 5;55(1):97-102.PMID: 8839816 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.

    Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G; BENEDICT Study Group.

    J Am Soc Nephrol. 2006 Dec;17(12):3472-81. Epub 2006 Nov 2.PMID: 17082240 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.

    Kirchengast M.

    J Hypertens Suppl. 1997 Mar;15(2):S27-33. Review.PMID: 9218195 [PubMed - indexed for MEDLINE]Related articles